Kanebo Ltd.

Inadequate control of contamination continues to be a common problem found in drug GMP warning letters, while insufficient raw material testing is a growing problem seen in the 20 drug GMP warning let

[Kao Corp.] ’s Kanebo Ltd. Cosmetics unit is recalling from Japan, Hong Kong and other Asian markets an array of products designed to brighten skin with its Rhododenol ingredient, which has been l

[Kao Corp.] ’s Kanebo Ltd. Cosmetics unit is recalling from Japan, Hong Kong and other Asian markets an array of products designed to brighten skin with its Rhododenol ingredient, which has been l

Digene has established itsbona fides in HPV testing. But will its assay change medical practice and make the company a superstar? by Mark L. Ratner Reading the five-year-old IPO prospectus for Digene